Salting-out-assisted liquid–liquid extraction as a suitable approach for determination of methoxetamine in large sets of tissue samples
- 11 December 2015
- journal article
- research article
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 408 (4) , 1171-1181
Abstract
A new designer drug, a dissociative anesthetic, and a putative N-methyl-d-aspartate receptor antagonist, methoxetamine (MXE) noted by the EU Early Warning System has been already identified as a cause of several fatalities worldwide. The primary objective of this work was to develop a suitable sample preparation method allowing for isolation of MXE and its main metabolites in high yields from rat brain, liver, and lungs. For the purpose of the project, MXE and five metabolites were synthesized in-house, specifically O-desmethyl-normethoxetamine, O-desmethylmethoxetamine, dihydro-O-desmethylmethoxetamine, normethoxetamine, and dihydromethoxetamine. A sample preparation procedure consisted in the homogenization of the tissue applying salting-out-assisted liquid–liquid extraction (SALLE). A subsequent liquid chromatography-mass spectrometry (LC-MS) analysis was based on reversed-phased chromatography hyphenated with a triple quad MS system in a positive electrospray mode. Multiple reaction monitoring (MRM) was used for qualification and quantification of the analytes. The quantification was based on the application of an isotopically labeled internal standard, normethoxetamine-d3. The matrix-matched calibrations were prepared for each type of matrix with regression coefficients 0.9943–1.0000. The calibration curves were linear in the concentration range of 2.5–250 ng g−1. Limits of quantification (LOQs) were estimated as 2.5 and 5 ng g−1, respectively. Recovery (80–117 %) and matrix effect (94–110 %) at 100 ng g−1 and intra- and inter-day accuracy and precision at low (2.5 ng g−1), middle (25 ng g−1), and upper (250 ng g−1) concentration levels for all the analytes in all three types of tissues were also determined. The developed analytical method was applied to a set of real samples gathered in toxicological trials on rats and MXE, and its metabolites were determined successfully.Keywords
Funding Information
- Ministry of Interior of the Czech Republic (VG20122015075)
- Ministry of Education of the Czech Republic (MSMT No 20/2015)
This publication has 18 references indexed in Scilit:
- Methoxetamine – a novel recreational drug with potent hallucinogenic propertiesToxicology Letters, 2014
- Acute methoxetamine and amphetamine poisoning with fatal outcome: A case reportInternational Journal of Occupational Medicine and Environmental Health, 2014
- Methoxetamine Misuse and ToxicityJournal of Studies on Alcohol and Drugs, 2013
- Multicomponent LC–MS/MS screening method for detection of new psychoactive drugs, legal highs, in urine—Experience from the Swedish populationJournal of Chromatography B, 2013
- Methoxetamine (MXE) – A Phenomenological Study of Experiences Induced by a “Legal High” from the InternetJournal of Psychoactive Drugs, 2013
- Ketamine-derived designer drug methoxetamine: metabolism including isoenzyme kinetics and toxicological detectability using GC-MS and LC-(HR-)MS nAnalytical and Bioanalytical Chemistry, 2013
- From the Street to the Laboratory: Analytical Profiles of Methoxetamine, 3-Methoxyeticyclidine and 3-Methoxyphencyclidine and their Determination in Three Biological MatricesJournal of Analytical Toxicology, 2013
- From “Special K” to “Special M”: The Evolution of the Recreational Use of Ketamine and MethoxetamineCNS Neuroscience & Therapeutics, 2013
- An automated method for measurement of methoxetamine in human plasma by use of turbulent flow on-line extraction coupled with liquid chromatography and mass spectrometric detectionAnalytical and Bioanalytical Chemistry, 2012
- Methoxetamine associated reversible cerebellar toxicity: Three cases with analytical confirmationClinical Toxicology, 2012